Er-Kim has announced that they have been appointed by Immunocore as the distribution and commercialisation partner for KIMMTRAK Turkey and across the Middle East, North Africa, Caucasus and the Commonwealth of Independent States (CIS) regions.
4basebio, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, has announced refreshed branding and the launch of its new website.
Vetter, a global Contract Development and Manufacturing Organisation (CDMO), celebrated the start of construction for its new clinical manufacturing site in Des Plaines with an official groundbreaking ceremony on 26th June.
Aenova, a global contract development and manufacturing organisation (CDMO), is investing in a new cold chain warehouse at its sterile site in Latina, Italy.
IMCD, a partner for the distribution and formulation of speciality chemicals and ingredients, has announced the acquisition of 100% of the shares in Trichem Healthcare Private Limited, Trichem Lifesciences Limited and Chemistry & Health FZ.
Platinum Press, a provider of printed packaging solutions specialising in labels, folding cartons, leaflets, foil lidding and flexible packaging, has commenced large-scale production runs on two new Rapida 106 X Printing Presses from Koenig & Bauer.
ProFound Therapeutics has announced a four-year collaboration with Novartis to discover and develop novel therapeutics for cardiovascular disease leveraging its ProFoundry Platform.
Speaking at the Medicines for Europe Annual Conference, Michal Nitka, SVP head generics Europe & global head OTC at Teva Pharmaceuticals, highlights the essential role of a resilient, competitive, and environmentally sustainable pharma industry.
Enhanced Genomics, a biotechnology company, has announced a strategic partnership with The ALBORADA Drug Discovery Institute at the University of Cambridge.
OutSee has announced it has secured £1.8M in seed funding, led by Ahren Innovation Capital and with additional investment from Kadmos Capital, Empirical Ventures and Panacea Ventures.
INTEGRA Biosciences’ liquid handling solutions and pipette automation software are helping 3T Biosciences to enhance the reproducibility and productivity of its pipetting workflows, accelerating the discovery of novel cancer targets and therapeutics.
